Amonkar, M M
Merck & Co., Inc., Rahway, NJ, USA (United States)
3 papers on CoChatORCID 0000-0003-4135-4211
Most cited papers
- Verified
Obesity and health-related quality of life: a cross-sectional analysis of the US population
Hassan, M. K., Joshi, A. V., Madhavan, S. S., & Amonkar, M. M. (2003) · International Journal of Obesity
Obesity, Physical Activity, DietObesity and Health Practices
Cited by 314
- Verified
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): An open-label, randomised, phase 3 trial
Andre, T., Amonkar, M., Norquist, J. M., Shiu, K.-K., Kim, T. W., Jensen, B. V., Jensen, L. H., Punt, C. J. A., Smith, D., Garcia-Carbonero, R., et al. (2021) · The Lancet Oncology
Colorectal Cancer Treatments and StudiesGenetic factors in colorectal cancer
Cited by 209
- Verified
Analysis of Costs Associated With Administration of Intravenous Single-Drug Therapies in Metastatic Breast Cancer in a U.S. Population
Kruse, G. B., Amonkar, M. M., Smith, G., Skonieczny, D. C., & Stavrakas, S. (2008) · Journal of Managed Care Pharmacy
Economic and Financial Impacts of CancerHealth Systems, Economic Evaluations, Quality of Life
Cited by 44
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free